¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"eosinophil count"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • eosinophil
    È£»ê±¸
  • eosinophil adenoma
    È£»ê»ùÁ¾
  • eosinophil granule
    È£»ê°ú¸³
  • eosinophil leukocyte
    È£»ê¹éÇ÷±¸, È£»ê±¸
  • eosinophil stimulation promotor
    È£»ê±¸ÀÚ±ØÃËÁøÁ¦
  • automated differential count
    ÀÚµ¿°¨º°°è»ê
  • blood count
    Ç÷±¸°è»ê
  • colony count
    Áý¶ô¼ö, Áý¶ô°è»ê
  • complete blood count
    ¿ÂÇ÷±¸°è»ê, ÀüüÇ÷±¸°è»ê
  • count
    1. °è»ê 2. °è¼ö
  • differential blood count
    °¨º°Ç÷±¸°è»ê
  • differential count
    °¨º°°è»ê
  • differential leukocyte count
    ¹éÇ÷±¸°¨º°°è¼ö
  • plating colony count technique
    ÆòÆÇ¹è¾çÁý¶ô°è¼ö¹ý
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • eosinophil
    È£»ê±¸
  • count
    °è»ê, ¼ö
  • blood count
    Ç÷±¸°è»ê
  • complete blood count
    ¿ÂÇ÷±¸°è»ê, ÀüüÇ÷±¸°è»ê
  • radioactivity count
    ¹æ»ç´ÉÃøÁ¤
  • reticulocyte count
    ±×¹°ÀûÇ÷±¸°è»ê, ¼¼¸Á¼¼Æ÷°è»ê
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • eosinophil adenoma
    È£»ê»ùÁ¾
  • eosinophil
    È£»ê±¸
  • eosinophil granule
    È£»ê¼º°ú¸³
  • eosinophil leukocyte
    È£»ê¼º¹éÇ÷±¸
  • eosinophil chemotactic factor
    È£»ê±¸È­ÇÐÁÖ¼ºÀÎÀÚ, È£»ê±¸È­Çнò¸²ÀÎÀÚ
  • eosinophil stimulation promotor
    È£»ê±¸ÀÚ±ØÃËÁøÁ¦
  • automated differential count
    ÀÚµ¿°¨º°°è»ê
  • blood count
    Ç÷±¸°è»ê
  • count
    °è»ê, ¼ö
  • colony count
    Áý¶ô¼ö, Áý¶ô°è»ê
  • complete blood count
    ¿ÂÇ÷±¸°è»ê, ÀüüÇ÷±¸°è»ê
  • differential count
    °¨º°°è»ê
  • differential blood count
    °¨º°Ç÷±¸°è»ê
  • differential leukocyte count
    °¨º°¹éÇ÷±¸°è»ê
  • egg count
    Ãæ¶õ¼ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • CBC =>complete blood count
    ÀüÇ÷±¸°è»ê(Ä¡)
  • plating colony count technique
    ÆòÆÇ¹è¾ç Áý¶ô°è¼ö¹ý
  • radioactivity count
    ¹æ»ç´ÉÃøÁ¤
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • eosinophil
    È£»ê±¸
  • eosinophil
    È£»ê±¸(û¿ß«Ï¹)
  • eosinophil
    È£»ê±¸(û¿ß«Ï¹)
  • eosinophil =eosinophile
    È£»ê±¸¼º(û¿ß«Ï¹àõ)ÀÇ, È£»ê±¸(û¿ß«Ï¹), È£»ê¼º ÀÇ
  • eosinophil =eosinophile
    È£»ê±¸¼º(Ì´Ë×Ë´ËÛ)ÀÇ, È£»ê±¸(Ì´Ë×Ë´), È£»ê¼º ÀÇ.
  • eosinophil adenoma
    È£»ê¼º ¼±Á¾.
  • eosinophil cationic protein
    È£»ê±¸¾çÀ̿´ܹé
  • eosinophil chemotactic factor
    È£»ê±¸ È­ÇÐÁÖ¼ºÀÎÀÚ
  • eosinophil chemotactic factor =ECF
    È£»ê±¸ È­ÇÐÁÖ¼ºÀÎÀÚ.
  • eosinophil granule
    È£»ê±¸¼º °ú¸³(¡­Î¨í£).
  • eosinophil leukocyte
    »êÈ£¼º ¹éÇ÷±¸(¡­ÛÜúìϹ).ÀÇÈ£»ê¼º ¹éÇ÷±¸.
  • eosinophil leukocyte
    »êÈ£¼º ¹éÇ÷±¸(?ËÑÌ´Ë´).[ÀÇ]È£»ê¼º ¹éÇ÷±¸.
  • eosinophil production
    È£»ê±¸»ý¼º
  • eosinophil protein X
    È£»ê±¸´Ü¹é X
  • eosinophil stimulation promotor
    È£»ê±¸ÀÚ±ØÃËÁøÁ¦.
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • dilution egg count
    Èñ¼®Ãæ¶õ°è»ê
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • count
    °è¼ö(ͪâ¦)
  • plate count
    ÆòÆÇ°è¼ö(øÁ÷ùÌõâ¦)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • eosinophil
    È£»ê±¸¼ºÀÇ, È£»ê±¸, È£»ê¼ºÀÇ
  • count
    °è¼ö
  • count per minute
    ÀϺа£Ä«¿îÆ®
  • radioactivity count
    ¹æ»ç´É°è¼ö
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
TEC total electron count; total eosinophil count; total exchange capacity; transient erythroblastopenia ...
Diff. Differential count; ¹éÇ÷±¸ °¨º° °è»ê
  = diff. count
diff. count differential count; ¹éÇ÷±¸ °¨º° °è»ê
  = Diff.
WBC well baby care/clinic; white blood cell; white blood cell count; whole blood cell count
PIE   1) Post-Infectious Encephalomyelitis
  2) Pulmonary Interstitial Emphysema;...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
TEC Total eosinophil count
EO Eosinophil
ECP Eosinophil Cationic Protein
ECA Eosinophil chemotactic activity
ECF Eosinophil chemotactic factor
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • eosinophil adenoma
    È£»ê¼º ¼±Á¾
  • eosinophil chemotactic factor
    È£»ê±¸ È­ÇÐ ÁÖ¼º ÀÎÀÚ
  • eosinophil granule
    È£»ê±¸¼º °ú¸³
  • eosinophil metamyelocyte
    »êÈ£¼º ÈÄ °ñ¼ö ¼¼Æ÷
  • eosinophil protein X
    È£»ê±¸ ´Ü¹é X
  • eosinophil-derived neurotoxin
    È£»ê±¸ À¯·¡ ½Å°æ µ¶¼Ò
  • average count
    Æò±Õ ¹ø¼ö
  • blood count
    Ç÷±¸°è»ê
    ÀÏÁ¤ÀÇ Ç÷¾×·® 1§§Áß À¯Çü ¼ººÐ¼öÀÇ ÃøÁ¤.
  • cell count
    ¼¼Æ÷ ¼ö
    ´ÜÀ§ ºÎÇÇ´ç Æ÷ÇԵǾî ÀÖ´Â ¼¼Æ÷ ¼ö·Î¼­ º¸Åë ´ÜÀ§ ºÎÇÇ´ç Ç÷¾×¿¡ Æ÷ÇԵǾî ÀÖ´Â ÀûÇ÷±¸¿Í/ȤÀº ¹éÇ÷±¸¸¦ ¸»ÇÑ´Ù.
  • complete blood count
    ÀüÇ÷ °Ë»ç, ÀüÇ÷±¸ °è»ê
  • corrected reticulocyte count
    ?
  • count per minute
    ÀϺа£ Ä«¿îÆ®
  • dust count
    ¸ÕÁö °è»ê¹ý
  • full blood count
    ÀüÇ÷ ÃøÁ¤, Ç÷¾× ÃÑ·® ¼ö
  • leukocyte count
    ¹éÇ÷±¸ ¼ö »êÁ¤
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
eosinophil count A measurement (cells per microlitre) of the number of eosinophils in a blood specimen. This measurement, also called the absolute eosinophil count, is useful in the evaluation of autoimmune disease, allergies, eczema, leukaemia, asthma and hay fever. Normal absolute eosinophil counts are less than 350 cells/mcl (microlitre).
(27 Sep 1997)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
absolute eosinophil count <haematology, investigation> A measurement (cells per microlitre) of the number of eosinophils in a blood specimen.
This measurement is useful in the evaluation of autoimmune disease, allergies, eczema, leukaemia, asthma and hay fever. Normal absolute eosinophil counts are less than 350 cells/mcl (microlitre).
(27 Sep 1997)
chemotactic factors, eosinophil Cytotaxins liberated from normal or invading cells that specifically attract eosinophils; they may be complement fragments, lymphokines, neutrophil products, histamine or other; the best known is the tetrapeptide ecf-a, released mainly by mast cells.
(12 Dec 1998)
eosinophil Polymorphonuclear leucocyte (granulocyte) of the myeloid series, of which the granules stain red with eosin. Phagocytic, particularly associated with helminth infections and with hypersensitivity.
(18 Nov 1997)
eosinophil adenoma <endocrinology, oncology, tumour> A benign tumour, usually found in the anterior lobe of the pituitary gland, whose cells stain with acid dyes.
Such pituitary tumours may give rise to excessive secretion of growth hormone, resulting in gigantism or acromegaly. A specific type of acidophil adenoma may give rise to nonpuerperal galactorrhoea.
(25 Jun 1999)
eosinophil cationic protein <protein> Arginine rich protein (21 kD) in granules of eosinophils, that damages schistosomula in vitro. Not the same as the MBP (major basic protein) of the granules.
(18 Nov 1997)
eosinophil chemotactic factor of anaphylaxis A peptide (MW 500 to 600) that is chemotactic for eosinophilic leukocytes and is released from disrupted mast cells.
(05 Mar 2000)
eosinophil chemotactic peptide <protein> Tetrapeptides (of which two are identified: VGSE and AGSE) released by mast cells and that are said to both attract and activate eosinophils.
(18 Nov 1997)
eosinophil granule A granule that stains with eosin.
(05 Mar 2000)
eosinophil peroxidase <enzyme> Peroxidase from eosinophil granules distinct from myeloperoxidase; claimed to enhance destruction of fungi, bacteria, schistosomula, toxoplasma, trypanosoma, mast cells, tumour cells in presence of exogenous h2o2 and halide
Registry number: EC 1.11.1.-
(26 Jun 1999)
absolute CD4 count The number of helper T-lymphocytes in a cubic millimeter of blood. With HIV, the absolute CD4 count declines as the infection progresses. The absolute CD4 count is frequently used to monitor the extent of immune suppression in persons with HIV. Also called a T4 count.
(12 Dec 1998)
Addis count A quantitative enumeration of the red blood count, white blood count, and casts in a 12-hr urine specimen; used to follow the progress of known renal disease.
(05 Mar 2000)
Arneth count The percentage distribution of polymorphonuclear neutrophils, based on the number of lobes in the nuclei (from 1 to 5).
See: Arneth index.
(05 Mar 2000)
b and t cell count A test that measures the respective quantities of B lymphocytes and T lymphocytes. This test is often performed in the analysis of an immune deficiency disorder. Normal values include: 68 to 75% of total lymphocytes are T lymphocytes and 10 to 20% are B lymphocytes.
Increased T-cell counts can indicate infectious mononucleosis, acute lymphocytic leukaemia or multiple myeloma.
Increased B lymphocytes can indicate chronic lymphocytic leukaemia, multiple myeloma, Waldenstrom's macroglobulinaemia or Di George syndrome. Decreased T-cells may indicate congenital T-cell deficiency, Wiskott-Aldrich syndrome or AIDS. Decreased B-cells may indicate acute lymphocytic leukaemia or a congenital immunoglobulin deficiency disorder.
(27 Sep 1997)
blood cell count A count of the number of leukocytes and erythrocytes per unit volume in a sample of venous blood. A complete blood count (cbc) also includes measurement of the haemoglobin, haematocrit, and erythrocyte indices.
(12 Dec 1998)
blood count <haematology, investigation> The determination of the proper number of red blood cells, white blood cells and platelets are present in the patients blood.
Acronym: FBC
(16 Dec 1997)
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 1 ÆäÀÌÁö: 1
  • Eosinophil count - absolute - »õâ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • count
    ¼¼´Ù,°è»êÇÏ´Ù
  • count for
    Áß¿äÇÏ´Ù
  • count in
    ¼À¿¡ ³Ö´Ù; ÇÑÆÐ¿¡ ³¢¿öÁÖ´Ù
  • count on
    ÀÇÁöÇÏ´Ù; ¹Ï´Ù
  • count out
    Á¦¿ÜÇÏ´Ù
  • count up
    ÇÕ°èÇÏ´Ù
  • blood count
    Ç÷±¸¼öÃøÁ¤
  • coli count
    (¹Ù´å¹° ¼Ó µîÀÇ)´ëÀå±ÕÀÇ ¼ö
  • count
    (ÃѼö¸¦ ¾Ë±âÀ§ÇØ)¼¼´Ù;°è»êÇÏ´Ù;¼À¿¡ ³Ö´Ù;Æ÷ÇÔ½ÃŰ´Ù;...ÀÇ Å¿À¸·Î ÇÏ´Ù;À¸·Î µ¹¸®´Ù;(...À»...À̶ó°í)»ý°¢ÇÏ´Ù;°£ÁÖÇÏ´Ù;¼ö¸¦ ¼¼´Ù;°è»êÇÏ´Ù;(...ºÎÅÍ...±îÁö)¼¼´Ù;¼À(°è»ê)¿¡ ³Ö´Ù;(¼À¿¡ ³ÖÀ»)°¡Ä¡°¡ ÀÖ´Ù;Áß¿äÇÏ´Ù;(..ÀÇ)°¡Ä¡(°ª¾îÄ¡)°¡ ÀÖ´Ù;(...¾È¿¡)Æ÷ÇԵǴÙ;(...À¸
  • count noun
    °¡»ê ¸í»ç
  • count palatine
    Èı⠷θ¶Á¦±¹ ÃÖ°í »ç·É°ü;µ¶ÀÏ È²Á¦ÀÇ Çã°¡·Î ÀϺΠ¿Õ±ÇÀ» Àڱ⠿µÅä¿¡¼­ Çà»çÇÏ´ø ¿µÁÖ;À×±Û·£µå ¹× ¾ÆÀÏ·£µåÀÇ ÁÖ ¿µÁÖ
  • count-out
    Á¤Á·¼ö(40¸í)¹Ì´Þ·Î ÀÎÇÑ À¯È¸;Á¦¿ÜÇ¥(¿¡ ÀÇÇÑ ³«¼±ÀÚ);Ä«¿îÆ®¾Æ¿ô a
  • head count
    ¿©·Ð(±¹¼¼)Á¶»ç
  • nose count
    Àοø¼ö ¼¼±â;´Ù¼ö°á
  • pollen count
    ²É°¡·çÀÇ ¼ö !
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á